Abstract:Abstract Background: The rapidly growing research in leukemia has provided unequivocal proof that cancer stem cells exist in acute myeloid leukemia. However, the mechanisms of the growth and self-renewal of acute myeloid leukemia stem cells (LSCs), which play an important role in the development of AML, were still elusive. Methods: We first used a trained stemness index model based on a recently described machine learning method one-class logistic regression (OCLR) to score AML samples. We then obtained the mRNA expression based-index (mRNAsi), DNA methylation based-index (mDNAsi), and epigenetic regulation based-index (EREG-mRNAsi). With the acquired three stemness indices, we investigated the relationship between the stemness index and the tumor immune microenvironment/somatic mutation, clinical characteristics of AML patients. Furthermore, a weighted gene co-expression network analysis (WGCNA) and protein-protein interaction (PPI) network were performed to obtain key genes associated with the stemness index. Bedsides, GO and KEGG enrichment analysis was performed to explore the biological functions. Finally, we validated the key genes by applying it to the Oncomine and GEO datasets.Result: The results suggested that EREG-mRNAsi might accurately predict overall survival (OS) in AML patients from TCGA, while the mRNAsi and mDNAsi was not significantly statistically associated with the OS. Furthermore, the mRNAsi was significantly correlated with the clinical characteristics of the FAB category, age, gender, immune score, WT1, and CEBPA mutation. Additionally, the EREG-mRNAsi was significantly associated with the cytogenetics risk category, TP53 mutation. The mDNAsi was significantly associated with the FAB-category, NPM1, IDH1, IDH2, and DNMT3A mutation. Several key genes related to the stemness index of AML were indicated to be possible and promising therapeutic targets for inhibiting LSCs in AML.Conclusions: Our research based on machine learning and WGCNA analysis revealed a set of key genes contributed to the stemness index of AML. These genes may become therapeutic targets to inhibit the LSCs of AML in the future.

Molecular Mechanisms for Stemness Maintenance of Acute Myeloid Leukemia Stem Cells

[Progress in the Studies of Acute Myelogenous Leukemia Stem Cell].

Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells

Leukemia Stem Cells: the Root of Chronic Myeloid Leukemia

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

Cellular and Molecular State of Myeloid Leukemia Stem Cells.

Targeting Acute Myeloid Leukemia Stem Cells: Current Therapies in Development and Potential Strategies with New Dimensions

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells

Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.

Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia

Machine Learning and Integrative Analysis Reveals Stemness Index-associated Signature in Acute Myeloid Leukemia

The epigenetic state of the cell of origin defines mechanisms of leukemogenesis

Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses

Metabolic dependencies of acute myeloid leukemia stem cells

Re-Evaluation of Various Molecular Targets Located on Cd34(+)Cd38(-)Lin(-) Leukemia Stem Cells and Other Cell Subsets in Pediatric Acute Myeloid Leukemia

Biology and relevance of human acute myeloid leukemia stem cells.

Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance

Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells Via a KDM4C-ALKBH5-AXL Signaling Axis.